The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

Ozempic, a diabetes medication by Novo Nordisk, has gained popularity for its weight loss effects, sparking debate.

To make $1 million in the stock market, you don't need to invest a fortune. But you'll definitely want to take the time to ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

RELATED: Patient Shares Another Ozempic Side Effect: "You Never Know What Will Set It Off." GLP-1 agonists are a class of ...

Leerink Partnrs analyst D. Risinger now expects that the company will earn $1.24 per share for the quarter, […] ...

Tirzepatide-based medicines Mounjaro for diabetes and Zepbound for obesity have led the charge, contributing $3.1 billion and $1.2 billion to Lilly's revenues for the period, respectively ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 3, 2024. REUTERS/Brendan McDermid/File Photo The Dow Jones Industrial Average and S&P 500 chalked up ...

The diplomatic tensions between India and Canada over the murder of Khalistan activist Hardeep Singh Nijjar have serious implications for the Sikh community globally. Satnam Singh Chahal of NAPA ...

The economic mood may feel different than September as the economy appears to be heating back up. But very little in terms of expectations — and their effect on stocks — has shifted. If you ...